Toxic Myelitis and Arachnoiditis After Intrathecal Delivery of Bupivacaine via an Implanted Drug Delivery System: Case Report and Review of the Literature

The off-label usage of amino-amide anesthetics in intrathecal drug delivery systems (IDDS) for the treatment of chronic non-malignant and malignant pain is supported in the polyanalgesic consensus guidelines as a second-line adjunctive therapy. Although strong evidence for its clinical efficacy is l...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Meng, Dalm, Brian, Simpson, Richard K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2018
Materias:
Pain Management
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922505/
https://www.ncbi.nlm.nih.gov/pubmed/29719742
http://dx.doi.org/10.7759/cureus.2240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922505/
https://www.ncbi.nlm.nih.gov/pubmed/29719742
http://dx.doi.org/10.7759/cureus.2240

Ejemplares similares